NOVOLOG (PHARM-UP 1966) LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.9 ILa | -2.73% |
|
-0.13% | +10.42% |
| Sales 2022 | 1.51B 407M 151B | Sales 2023 | 1.64B 443M 164B | Capitalization | 726M 196M 72.57B |
|---|---|---|---|---|---|
| Net income 2022 | 47M 12.68M 4.7B | Net income 2023 | -42M -11.33M -4.2B | EV / Sales 2022 | 0.96 x |
| Net Debt 2022 | 39.97M 10.78M 4B | Net cash position 2023 | 17.76M 4.79M 1.78B | EV / Sales 2023 | 0.43 x |
| P/E ratio 2022 |
29.8
x | P/E ratio 2023 |
-17.2
x | Employees | 955 |
| Yield 2022 |
2.37% | Yield 2023 |
2.07% | Free-Float | 64.69% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.73% | ||
| 1 week | -0.13% | ||
| 1 month | +0.84% | ||
| 3 months | +9.80% | ||
| 6 months | +20.32% | ||
| Current year | +10.42% |
1 week
155.00
163.80
1 month
148.30164.00
Current year
136.20164.00
1 year
127.20211.40
3 years
127.20369.20
5 years
127.20369.20
10 years
103.00369.20
| Managers | Title | Age | Since |
|---|---|---|---|
Eran Taus
CEO | Chief Executive Officer | 59 | 17-07-31 |
Amir Shahar
DFI | Director of Finance/CFO | 48 | 20-08-26 |
Noga Kababia
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | - |
Tamar Gottlieb
BRD | Director/Board Member | 67 | 22-11-19 |
Miri Naveh
BRD | Director/Board Member | 67 | 17-05-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-30 | 156.9 | -2.73% | 129,588 |
| 24-05-29 | 161.3 | -0.19% | 174,791 |
| 24-05-28 | 161.6 | +0.19% | 281,386 |
| 24-05-27 | 161.3 | +0.25% | 1,361,025 |
| 24-05-26 | 160.9 | +2.42% | 86,154 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 30, 2024 at 10:24 am EDT
More quotes
Novolog Pharm Up 1966 Ltd, formerly Pharm Up Ltd, is an Israel-based company, which operates in the health logistics sector. The Company is a logistical partner for domestic and multinational pharmaceutical and medical device companies operating in Israel. It mainly serves pharmacies, hospitals, and patients at home. The Company operates through its subsidiaries, which include: Care for Life-Professional Nurses Service, which provides a range of in-home services for patients by trained nurses and trained assistants, as well as Trialog-Clinical Trial Logistics, which specializes in logistics for clinical trials and works with pharmaceutical and Clinical Research Organization (CRO) companies that perform clinical trials in Israel.
Sector
Ground Freight & Logistics
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +10.42% | 216M | |
| +4.17% | 80.97B | |
| +3.48% | 74.17B | |
| -.--% | 26.71B | |
| -11.94% | 11.97B | |
| -0.02% | 10.11B | |
| -16.31% | 7.8B | |
| -14.12% | 6.95B | |
| +6.52% | 6.07B | |
| +5.57% | 5.32B |
- Stock Market
- Equities
- NVLG Stock
